Q3 Beats Undercut by $450M Settlement Charge; Shares Slide
ISRG sits 24% above its 52-week low of $328.57.
Summary
Intuitive Surgical beat on Q3, posting net income of $522.8 million, EPS of $1.49 and adjusted EPS of $3.00, yet the stock fell as a $450 million settlement charge weighed on the print. The charge is the new piece here — the headline numbers were already out via Dow Jones, but the settlement's drag on results and the negative share reaction are what traders are pricing. For a company of this size the charge is meaningful but not thesis-breaking; the question is whether it is a one-time legal hit or a sign of broader liability.
At the time of this announcement, ISRG was trading at $407.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $154.7B. The 52-week trading range was $328.57 to $603.88. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.